174 related articles for article (PubMed ID: 30085099)
41. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice.
Guibinga GH; Ebihara S; Nalbantoglu J; Holland P; Karpati G; Petrof BJ
Mol Ther; 2001 Nov; 4(5):499-507. PubMed ID: 11708887
[TBL] [Abstract][Full Text] [Related]
42. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
[TBL] [Abstract][Full Text] [Related]
43. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
44. Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy.
Moulton HM; Moulton JD
Biochim Biophys Acta; 2010 Dec; 1798(12):2296-303. PubMed ID: 20170628
[TBL] [Abstract][Full Text] [Related]
45. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
46. Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy.
Abou-Samra M; Boursereau R; Lecompte S; Noel L; Brichard SM
Am J Pathol; 2017 Jul; 187(7):1577-1585. PubMed ID: 28463682
[TBL] [Abstract][Full Text] [Related]
47. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy.
Desguerre I; Arnold L; Vignaud A; Cuvellier S; Yacoub-Youssef H; Gherardi RK; Chelly J; Chretien F; Mounier R; Ferry A; Chazaud B
Muscle Nerve; 2012 Jun; 45(6):803-14. PubMed ID: 22581532
[TBL] [Abstract][Full Text] [Related]
48. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
49. Identification and Function of Fibrocytes in Skeletal Muscle Injury Repair and Muscular Dystrophy.
Wang X; Zhao W; Ransohoff RM; Zhou L
J Immunol; 2016 Dec; 197(12):4750-4761. PubMed ID: 27913649
[TBL] [Abstract][Full Text] [Related]
50. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation.
Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A
Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403
[TBL] [Abstract][Full Text] [Related]
51. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
[TBL] [Abstract][Full Text] [Related]
52. Paeonia lactiflora extract improves the muscle function of mdx mice, an animal model of Duchenne muscular dystrophy, via downregulating the high mobility group box 1 protein.
Sim I; Jang J; Song J; Lee J; Lim H; Lee HJ; Hwang G; Kwon YV; Lee D; Yoon Y
J Ethnopharmacol; 2022 May; 289():115079. PubMed ID: 35149132
[TBL] [Abstract][Full Text] [Related]
53. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy.
Giordano C; Mojumdar K; Liang F; Lemaire C; Li T; Richardson J; Divangahi M; Qureshi S; Petrof BJ
Hum Mol Genet; 2015 Apr; 24(8):2147-62. PubMed ID: 25552658
[TBL] [Abstract][Full Text] [Related]
54. Chemotaxis and Immunoregulatory Function of Cardiac γδ T Cells in Dystrophin-Deficient Mice.
Cascabulho CM; Beghini DG; Meuser-Batista M; Penido C; Henriques-Pons A
J Immunol; 2016 Nov; 197(9):3531-3544. PubMed ID: 27707996
[TBL] [Abstract][Full Text] [Related]
55. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
56. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
[TBL] [Abstract][Full Text] [Related]
57. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
58. Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.
Manning J; Kulbida R; Rai P; Jensen L; Bouma J; Singh SP; O'Malley D; Yilmazer-Hanke D
Exp Physiol; 2014 Oct; 99(10):1370-86. PubMed ID: 24972834
[TBL] [Abstract][Full Text] [Related]
59. Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor.
Vidal B; Ardite E; Suelves M; Ruiz-Bonilla V; Janué A; Flick MJ; Degen JL; Serrano AL; Muñoz-Cánoves P
Hum Mol Genet; 2012 May; 21(9):1989-2004. PubMed ID: 22381526
[TBL] [Abstract][Full Text] [Related]
60. Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice.
Hinkle RT; Lefever FR; Dolan ET; Reichart DL; Dietrich JA; Gropp KE; Thacker RI; Demuth JP; Stevens PJ; Qu XA; Varbanov AR; Wang F; Isfort RJ
BMC Med; 2007 Jul; 5():18. PubMed ID: 17626629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
